NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20253169

Company北京百奥药业有限责任公司

Registration Date

January 14, 2025

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg（以氨氯地平计）

Drug Type

化学药品

Registration Date

January 14, 2025

Company Information

Applicant Company

Company Name北京百奥药业有限责任公司

Company Address

北京市昌平区科技园区超前路29号101室

Manufacturing Company

Company Name北京百奥药业有限责任公司

Company Address

北京市昌平区科技园区超前路29号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氨氯地平片 - NMPA 批准文号 | MedPath